NEWS
Navinta received FDA approval (January 16, 2019) ANDA 211251,
Navinta received FDA approval (September 11, 2018) ANDA 210179, CARMUSTINE.
Navinta received FDA approval (November 24, 2017) ANDA 206071, METHOCARBAMOL.
Navinta received FDA approval (July 19, 2017) ANDA 206561, INDOMETHACIN SODIUM.
Navinta received FDA approval (October 6, 2016) ANDA 207366, RIBAVIRIN.